Sarepta Therapeutics Inc
NASDAQ:SRPT

Watchlist Manager
Sarepta Therapeutics Inc Logo
Sarepta Therapeutics Inc
NASDAQ:SRPT
Watchlist
Price: 118.97 USD 0% Market Closed
Market Cap: 11.4B USD
Have any thoughts about
Sarepta Therapeutics Inc?
Write Note

Intrinsic Value

The intrinsic value of one SRPT stock under the Base Case scenario is 199.9 USD. Compared to the current market price of 118.97 USD, Sarepta Therapeutics Inc is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SRPT Intrinsic Value
199.9 USD
Undervaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sarepta Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for SRPT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about SRPT?
Bearish
Neutral
Bullish

Fundamental Analysis

118.97 USD
+0%
+0%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Sarepta Therapeutics Inc
US
Biotechnology
Market Cap
11.4B USD
IPO
Jun 4, 1997
Employees
840
United States of America
Market Cap
11.4B USD
Industry
Biotechnology
IPO
Jun 4, 1997
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Sarepta Therapeutics Inc

Provide an overview of the primary business activities
of Sarepta Therapeutics Inc.

What unique competitive advantages
does Sarepta Therapeutics Inc hold over its rivals?

What risks and challenges
does Sarepta Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Sarepta Therapeutics Inc recently?

Summarize the latest earnings call
of Sarepta Therapeutics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sarepta Therapeutics Inc.

Provide P/S
for Sarepta Therapeutics Inc.

Provide P/E
for Sarepta Therapeutics Inc.

Provide P/OCF
for Sarepta Therapeutics Inc.

Provide P/FCFE
for Sarepta Therapeutics Inc.

Provide P/B
for Sarepta Therapeutics Inc.

Provide EV/S
for Sarepta Therapeutics Inc.

Provide EV/GP
for Sarepta Therapeutics Inc.

Provide EV/EBITDA
for Sarepta Therapeutics Inc.

Provide EV/EBIT
for Sarepta Therapeutics Inc.

Provide EV/OCF
for Sarepta Therapeutics Inc.

Provide EV/FCFF
for Sarepta Therapeutics Inc.

Provide EV/IC
for Sarepta Therapeutics Inc.

Show me price targets
for Sarepta Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Sarepta Therapeutics Inc?

How accurate were the past Revenue estimates
for Sarepta Therapeutics Inc?

What are the Net Income projections
for Sarepta Therapeutics Inc?

How accurate were the past Net Income estimates
for Sarepta Therapeutics Inc?

What are the EPS projections
for Sarepta Therapeutics Inc?

How accurate were the past EPS estimates
for Sarepta Therapeutics Inc?

What are the EBIT projections
for Sarepta Therapeutics Inc?

How accurate were the past EBIT estimates
for Sarepta Therapeutics Inc?

Compare the revenue forecasts
for Sarepta Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sarepta Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sarepta Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sarepta Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Sarepta Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Sarepta Therapeutics Inc with its peers.

Analyze the financial leverage
of Sarepta Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Sarepta Therapeutics Inc.

Provide ROE
for Sarepta Therapeutics Inc.

Provide ROA
for Sarepta Therapeutics Inc.

Provide ROIC
for Sarepta Therapeutics Inc.

Provide ROCE
for Sarepta Therapeutics Inc.

Provide Gross Margin
for Sarepta Therapeutics Inc.

Provide Operating Margin
for Sarepta Therapeutics Inc.

Provide Net Margin
for Sarepta Therapeutics Inc.

Provide FCF Margin
for Sarepta Therapeutics Inc.

Show all solvency ratios
for Sarepta Therapeutics Inc.

Provide D/E Ratio
for Sarepta Therapeutics Inc.

Provide D/A Ratio
for Sarepta Therapeutics Inc.

Provide Interest Coverage Ratio
for Sarepta Therapeutics Inc.

Provide Altman Z-Score Ratio
for Sarepta Therapeutics Inc.

Provide Quick Ratio
for Sarepta Therapeutics Inc.

Provide Current Ratio
for Sarepta Therapeutics Inc.

Provide Cash Ratio
for Sarepta Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Sarepta Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Sarepta Therapeutics Inc?

What is the current Free Cash Flow
of Sarepta Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sarepta Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sarepta Therapeutics Inc

Current Assets 2.7B
Cash & Short-Term Investments 1.2B
Receivables 516m
Other Current Assets 971m
Non-Current Assets 914.6m
Long-Term Investments 186.5m
PP&E 446.7m
Intangibles 27.6m
Other Non-Current Assets 253.8m
Current Liabilities 699.5m
Accounts Payable 118.8m
Accrued Liabilities 221.4m
Other Current Liabilities 359.3m
Non-Current Liabilities 1.7B
Long-Term Debt 1.1B
Other Non-Current Liabilities 543.4m
Efficiency

Earnings Waterfall
Sarepta Therapeutics Inc

Revenue
1.6B USD
Cost of Revenue
-231m USD
Gross Profit
1.4B USD
Operating Expenses
-1.3B USD
Operating Income
81m USD
Other Expenses
40.8m USD
Net Income
121.8m USD

Free Cash Flow Analysis
Sarepta Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SRPT Profitability Score
Profitability Due Diligence

Sarepta Therapeutics Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROE is Increasing
41/100
Profitability
Score

Sarepta Therapeutics Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

SRPT Solvency Score
Solvency Due Diligence

Sarepta Therapeutics Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
50/100
Solvency
Score

Sarepta Therapeutics Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SRPT Price Targets Summary
Sarepta Therapeutics Inc

Wall Street analysts forecast SRPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SRPT is 187.55 USD with a low forecast of 80.8 USD and a high forecast of 229.95 USD.

Lowest
Price Target
80.8 USD
32% Downside
Average
Price Target
187.55 USD
58% Upside
Highest
Price Target
229.95 USD
93% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SRPT?

Click here to dive deeper.

Dividends

Sarepta Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SRPT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SRPT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

SRPT News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one SRPT stock?

The intrinsic value of one SRPT stock under the Base Case scenario is 199.9 USD.

Is SRPT stock undervalued or overvalued?

Compared to the current market price of 118.97 USD, Sarepta Therapeutics Inc is Undervalued by 40%.

Back to Top